Corrigendum to “Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals” [J. JCTE 2 (2015) 55–60]

In volume 2 of JCTE, page 57, in the first paragraph, the word androgen was inadvertently replaced with the word estrogen on 2 occasions. The sentence should read “In Kuroda et al. (2008), no breast carcinoma was found among FTM individuals (n = 56) who had been on androgen for an average of 11 months, while one breast carcinoma was found in among those FTM individuals (n = 130) who were not on androgen”.

The authors apologise for the inconvenience caused.